Food and Drug Administration Authorizes the Additional Monoclonal Antibody Sotrovimab for Treatment of COVID-19

aspr

 

[advanced_iframe src=”https://view.connect.hhs.gov/?qs=f4dc03f7664ecc11361f0bc99abe66443a512a54297b81dffd955eb78d870aaf44eb48b935b4848f4c7c1d149f60d11b934e2e7e426049831e839e531341ee878bdde0ea8efa4152″ width=”100%” height=”1600″]